Davita - Starrwood Home Training in Royal Oak, Michigan - Dialysis Center

Davita - Starrwood Home Training is a medicare approved dialysis facility center in Royal Oak, Michigan and it has 0 dialysis stations. It is located in Oakland county at 3425 Starr Rd Ste A, Royal Oak, MI, 48073. You can reach out to the office of Davita - Starrwood Home Training at (248) 549-0208. This dialysis clinic is managed and/or owned by Davita. Davita - Starrwood Home Training has the following ownership type - Profit. It was first certified by medicare in June, 2016. The medicare id for this facility is 232710 and it accepts patients under medicare ESRD program.

Name	Davita - Starrwood Home Training
Location	3425 Starr Rd Ste A, Royal Oak, Michigan
No. of Dialysis Stations	0
Medicare ID	232710
Managed By	Davita
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Davita - Starrwood Home Training from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

Dialysis patients with Hemoglobin data

7

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Peritoneal Dialysis

  Adult patients getting regular peritoneal dialysis at the center	16
  Adult patient months included in Kt/V greater than or equal to 1.7	111
  Percentage of adult patients getting regular peritoneal dialysis at the center	94
  Percentage of pediatric patients getting regular peritoneal dialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Starrwood Home Training with elevated calcium levels.

Patients with hypercalcemia	19
Hypercalcemia patient months	115
Hypercalcemia patients with serumcalcium greater than 10.2 mg	5
Patients with Serumphosphor	22
Patients with Serumphosphor less than 3.5 mg/dL	3
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	19
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	32
Patients with Serumphosphor from 5.6 to 7 mg/dL	30
Patients with Serumphosphor greater than 7 mg/dL	16

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	3
Patient months included in arterial venous fistula and catheter summaries	4
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	4
Hospitalization Rate in facility	(Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit